Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Healthtrust
US Department of Justice
Dow
QuintilesIMS
Chubb
Harvard Business School
Mallinckrodt
McKesson

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,632,803

« Back to Dashboard

Which drugs does patent 6,632,803 protect, and when does it expire?

Patent 6,632,803 protects VFEND and is included in one NDA.

This patent has fifty-six patent family members in forty-six countries.
Summary for Patent: 6,632,803
Title: Pharmaceutical formulations containing voriconazole
Abstract:The invention provides pharmaceutical formulation comprising voriconazole, or a pharmaceutically acceptable derivative thereof, and a sulfobutylether .beta.-cyclodextrin.
Inventor(s): Harding; Valerie Denise (Sandwich, GB)
Assignee: Pfizer Inc (New York, NY)
Application Number:09/402,289
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form;

Drugs Protected by US Patent 6,632,803

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Pf Prism Cv VFEND voriconazole INJECTABLE;IV (INFUSION) 021267-001 May 24, 2002 AP RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,632,803

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9713149Jun 21, 1997
PCT Information
PCT FiledJune 02, 1998PCT Application Number:PCT/EP98/03477
PCT Publication Date:December 30, 1998PCT Publication Number: WO98/58677

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Medtronic
Chinese Patent Office
UBS
Mallinckrodt
Cipla
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.